期刊文献+

基质金属蛋白酶2在食管鳞状细胞癌中的表达 被引量:3

Expression of matrix metalloproteinase-2 in esophageal squamous cell carcinoma
下载PDF
导出
摘要 目的探讨基质金属蛋白酶2(MMP-2)在食管鳞状细胞癌中的表达及其与临床病理特征的关系。方法采用免疫组织化学方法检测60例食管鳞状细胞癌组织和正常食管组织中MMP-2的表达,并分析MMP-2的表达与患者临床病理特征的关系。结果食管鳞状细胞癌和正常食管组织中MMP-2的阳性表达率分别为58.3%(35/60)和10.0%(6/60),食管鳞状细胞癌组织中MMP-2阳性表达率显著高于正常食管组织(P<0.01)。MMP-2表达与肿瘤浸润深度、淋巴结转移、原发肿瘤局部淋巴结远处转移分期有关(P<0.01),而与患者年龄、性别、肿瘤大体分型、肿瘤大小及分化程度无关(P>0.05)。结论 MMP-2可能在食管鳞状细胞癌的发生、发展中起重要作用,MMP-2表达的检测对食管鳞状细胞癌的早期诊断、预后判断有重要参考价值。 Objective To investigate the expression of matrix metalloproteinase-2( MMP-2) in esophageal squamous cell carcinoma( ESCC) and the relationship between MMP-2 expression and clinical pathological features. Methods The expression of MMP-2in sixty ESCC tissues and normal esophageal tissues was detected by immunohistochemical method. Then the relationship between MMP-2 expression and clinical pathological features was analyzed. Results The positive expression rate of MMP-2 in ESCC tissue and normal esophageal tissue was 58. 3%( 35 /60) and 10. 0%( 6 /60) respectively,the positive expression rate of MMP-2 in ESCC tissue was significantly higher than that in normal esophageal tissue( P〈0. 01). MMP-2 expression was related to tumor invasion depth,lymph node metastasis and tumor node metastasis staging( P〈0. 01). MMP-2 expression was not related to age,gender,general classification,tumor size and differentiation degree( P〉0. 05). Conclusion MMP-2 may play an important role in the occurrence and development of ESCC. The detection of MMP-2 expression has important value for early diagnosis and prognostic evaluation of ESCC.
出处 《新乡医学院学报》 CAS 2015年第9期839-840,843,共3页 Journal of Xinxiang Medical University
关键词 食管鳞状细胞癌 基质金属蛋白酶2 免疫组织化学 esophageal squamous cell carcinoma matrix metalloproteinase-2 immunohistochemistry
  • 相关文献

参考文献6

二级参考文献62

共引文献30

同被引文献51

  • 1于学燕,王永刚.MMP-2和MMP-3在非小细胞肺癌组织中的表达及意义[J].现代肿瘤医学,2005,13(4):461-463. 被引量:5
  • 2于秀文,程慧,王静芬.大肠癌组织中MMP-3的表达及其临床意义[J].中华肿瘤防治杂志,2006,13(1):45-47. 被引量:11
  • 3韦尉东,温浙盛,苏晓东,林鹏,戎铁华,陈丽昆.899例非小细胞肺癌完全切除术后的多因素生存分析[J].癌症,2007,26(11):1231-1236. 被引量:13
  • 4SUN Q,ZHAO C,XIA L,et al.High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma[J].Int J Clin Exp Pathol,2014,7(9):6157-6164.
  • 5AMALINEI C,CARUNTU I D,GIUSCA S E,et al.Matrix metalloproteinases involvement in pathologic conditions[J].Rom J Morphol Embryol,2010,51(2):215-228.
  • 6FANG S,JIN X,WANG R,et al.Polymorphisms in the MMP-1and MMP-3 promoter and non-small cell lung carcinoma in North China[J].Carcinogenesis,2005,26(2):481-486.
  • 7JAZIEH A R,HUSSAIN M,HOWINGTON J A,et al.Prognostic factors in patients with surgically resected stagesⅠandⅡnonsmall cell lung cancer[J].Ann Thorac Surg,2000,70(4):1168-1171.
  • 8TAKEDA S,FUKAI S,KOMATSU H,et al.Impact of large tumor size on survival after rescection of pathologically node negative(p NO)non-small cell lung cancer[J].Ann Thorac Surg,2005,79(4):1142-1146.
  • 9MOLINA J R,YANG P,CASSIVI S D,et al.Non-small cell lung cancer:epidemiology,risk factors,treatment,and survivorship[J].Mayo Chin Proc,2008,83(5):584-594.
  • 10EL-BADRAWY M K,YOUSEF A M,SHAALAN D,et al.Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum MMP-9 activity,pathologic type,and prognosis[J].J Bronchology Interv Pulmonol,2014,21(4):327-334.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部